Comments: NY A08075 | 2023-2024 | General Assembly

Bill Title: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration; allows for choice of any formulation and dosage of opioid reversal agent approved by the federal food and drug administration in the purchase, distribution or authorization to prescribe or dispense such products and in any expenditure used for the purchase or distribution of an opioid reversal agent.

Spectrum: Slight Partisan Bill (Democrat 9-5)

Status: (Introduced) 2024-04-09 - reported referred to ways and means [A08075 Detail]

Text: Latest bill text (Amended) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 New York A08075 at this time.

Social Comments on NY A08075

feedback